Insurance Trade Publication Urges Insurers to Prepare for Psychedelic Medicine
Insurance Business, a trade publication for the insurance sector, is now telling insurers to pay closer attention to psychedelic medicine. In a recent column, neuropsychopharmacologist Dr. Rayyan Zafar argued that psychedelic therapies are moving from fringe science into clinical, commercial, and regulatory reality. His larger point was not subtle. Insurers should not wait for the […]
Read More